DUSP16 and Alzheimer disease: Subsequently, transgenic mouse AD model 3xTg and non‐transgenic mouse AD model SAMP8 were used to investigate the potential improvements in hippocampal neurogenesis, synaptic transmission, and cognitive deficits through DUSP16 knockdown.